Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
107 Cards in this Set
- Front
- Back
#2 cause of death by any means in the US
(#1 for people under 85) |
cancer
|
|
Top 4 cancer killers
|
lung/bronchus
colorectal breast prostate |
|
top cancers - male
|
lung/bronchus
prostate colorectal |
|
top cancers - femal
|
lung/bronchus
breast colorectal |
|
cancers associated with smoking
|
lung bronchus, pancreas, bladder, uterus
|
|
cancer (definition)
|
disease of growth, cell division and differentiation
mass of tissue, the growth of which is incoordinate with the surrounding normal tissues and persists in the absence of the inciting stimulus |
|
parenchymal regeneration
|
--only in tissues that retain capacity to replicate
|
|
labile cells
|
continue to multiply throughout life
constantly replicating GI, sperm, hair, WBCs, platelets, RBCs |
|
stable cells
|
retain the latent capacity to regenerate
CAN repair/regenerate, but don't do so constantly glands, kidney tubules |
|
permanent cells
|
cannot regenerate
|
|
stromal repair
|
--proliferation of fibroblast and capillary buds (wound healing)
--subsequent laying down of collagen- produce scar --results in loss of specialized parenchymal function |
|
Hyperplasia
|
inc the # of cells in that particular area
-may be physiologic (breast development) or pathologic (cushing's syndrome, prostate enlarge w/age) -cells essentially normal (may have changes in appearance) |
|
Metaplasia
|
-adaptive substitution of one type for another type
-loss of specialized function -usually REVERSIBLE -occurs in epithelial and connective tissue |
|
atypical metaplasia
|
transition between metaplasia and dysplasia
|
|
dysplasia
|
-loss in uniformity
-loss in architectural orientation -mainly in epithelium -USUALLY reversible -malignant transformation sometimes associated (if malignant happens, NOT reversible) |
|
anaplasia
|
without form
-failure of differentation of reserve or stem cells -marked pleomorphism (vary in size/shape) |
|
marked pleomorphism
|
hallmark of cancer
|
|
neoplasia
|
NOT reversible to normal cell type
-abnormal mass of tissue -must kill cells to remove it -can be benign or malignant |
|
benign neoplasm
|
--based on judgement of tumor's potential behavior
--considered relatively innocent remain localized, no ability to spread, encapsulate, remove with local surgery --> survival of patient |
|
malignant neoplasm
|
CANCER
-invade and destroy adjacent structures -spread to distant sites to cause death (develop secondary tumors) -no encapsulation -grow by progressive infiltration, invasion, destruction, and penetration of surrounding tissue |
|
2 components of malignant neoplasm
|
parenchyma - proliferating neoplastic cells
stroma- supporting connective tissue, blood vessels and possibly lymphatics |
|
metastasis
|
anatomically distant cancer growth
-secondary tumor |
|
4 pathways which cancer disseminates
|
1. seeding through body cavities
2. direct transplantation (ie during surgery, help it move by disturb primary tumor) 3. lymphatic permeation (cells carried in lymph drainage) 4. transport through blood vessels |
|
differentitation
|
extent to which cells resemble their normal forebears and achieve their fully mature, specialized, functional and morphological characteristics.
prognosis depends on differentitation |
|
poorly differentiated cells
|
no specialized characteristics
resemble and embryonic, primative stem cell (anaplastic) |
|
well-differentiated cells
|
(benign)
have high level of specialization |
|
benign neoplasms
|
extremely well differentiated
-cell closely resemble tissue of origin -designated by attaching "-OMA" (ie, fibroma, adenoma, papilloma, glioma) many designations don't conform (ie, melanoma, hepatoma, lymphoma) |
|
malignant neoplasms
|
2 MAIN TYPES
sarcomas - arising from mesenchymal tissue carcinomas - arising from epithelial cells |
|
apoptosis
|
programmed cell death (programmed in DNA to die)
activation of p53 gene (if could activate in malignant cells- make kill themselves) common in embryonic development |
|
Tumor Grading
|
judgement call
based on degree of differentiation # reflects amount of anaplasia taking place (refers to LACK of differentiation) |
|
grade 1 tumor
|
well differentiated
cells resemble tissue of origin retain some specialized function |
|
grade 2 tumor
|
moderately differentiated
show less resemblance to tissue of origin more variation increase mitoses |
|
grade 3 tumor
|
poorly differentiated
cells don't resemble tissue of origin much variation increased mitoses |
|
grade 4 tumor
|
very poorly differentiated
no resemblance to tissue of origin great variation (very anaplastic) |
|
TNM System of Staging
|
T0 - T3 : primary tumor size (for that type of cancer)
N0 - N2 : lymph node involvement (# of nodes metastasized to) M0 - M2 : extent of metastasis (other than lymph nodes... how many secondary tumors found?) |
|
Cell cycle time
|
normal human cells: 1-2 days
MOST malignant cells: 2-3 days |
|
critical cell population
|
G0 phase cells
|
|
tumor cell growth rate
|
changes drastically through time
grows exponentially most of time asymmetrical sigmoidal curve |
|
factors influencing shape of tumor cell growth rate curve
|
hypoxia
nutrient/hormone supply toxic metabolites (TNF) inhibitory cell-cell communication caused by outgrowing vascular supply |
|
ischemic necrosis
|
tendency of tumor to outgrow it's vascular supply
|
|
Limit of detection
|
30 doublings
1.24 cm diameter, 1g 10^9 cells time required for most tumors to reach this cell count is <2 years! |
|
oncogenes
|
mutation that causes cancer
altered/mutated proto-oncogenes encode REGULATORY PROTEIN w/ dominant transforming properties (only 1 has to change) -cause overexpression of growth-related gene products --> tumor formation DOMINANT EFFECT |
|
proto-oncogenes
|
fxn in regulation of normal cell growth and/or differentiation
mutate to become oncogenes |
|
tumor suppressor genes
|
control/inhibit cell growth
mutations in these genes may remove growth inhibition a RECESSIVE trait (requires both copies of gene to be effected) |
|
tumor drug dosing
|
each dose kills same PROPORTION of cells, not same #
multiple courses needed to effect a cure administered cyclic fashion -- (cell rescue) |
|
cachexia
|
wasting
undergoing pain, nausea, etc. TNF can cause this |
|
multiple cell accidents
|
several independent accidents must occur in 1 cell for tumor development to begin.
|
|
corpus callosum
|
connection between right/left and front/back
executive center of brain |
|
hypothalamus
|
endocrine center (regulates hormone release from pituitary)
autonomic fxns behavior center |
|
thalamus
|
"relay center" of brain
every sensory system sends projections through, except olfaction, vision and hearing |
|
occipital cortex
|
primary visual processing area
|
|
frontal cortex
|
primary motor processing center
where Broca's area is found cortical and subcortical projection fibers |
|
raphae nuclei
|
inhibitory center of reticular activating system
where all seretonin cell bodies are localized |
|
3 structures part of basal ganglia
|
caudate nucleus
globus pallidus putamen |
|
locus ceruleus
|
location of norep. cell bodies
|
|
4 lobes of cerebrum
|
frontal, temporal, occipital, parietal
|
|
vesticular release of neurotransmitters is mostly _______ dependent
|
ca++
|
|
ligand gated ionophores
|
FAST
drug or NT binds to part on outside of cell M2 region lining the channel |
|
membrane bound enzymes
|
SLOW
activates intracellular enzymes (enz activates second messenger system) 1 MSR |
|
g-protein superfamily
|
SLOW
g-protein alpha subunit determines the effector system 7 MSRs active when alpha subunit is detached |
|
Go
|
INHIBITS Ca channels
|
|
Gs
|
ACTIVATES Ca channels
ACTIVATES Adenylate cyclase to INC cAMP production |
|
Gi
|
ACTIVATES potassium channels
INHIBITS Adenylate cyclase to DEC cAMP production |
|
Gq
|
activates PLC to make IP3 and DAG
|
|
excitatory amino acids
|
glutamate, aspartate
|
|
chemoreceptors
|
o2, co2, h+, taste, smell
|
|
mechanoreceptors
|
pressure, tension, vision, vibration, position
|
|
electroreceptors
|
fish - lateral line
|
|
thermoreceptors
|
heat/cold
|
|
photoreceptors
|
vision
|
|
nociceptors
|
pain / tissue damage
|
|
sensory receptors
characteristics |
fxn as transducers
convert 1 form energy (stimulus) to another form (generator potential) highly selective for specific stimulus modalities |
|
generator potentials
|
graded
vary w/stimulus strength (NOT all or none) must reach threshold to produce a.p. |
|
first order neurons
|
primary afferent neuron
peripheral ending fxns as sensory receptor OR receives input from accessory sensory cell cell body usually in dorsal root ganglion or cranial nerve ganglion |
|
second order neurons
|
usually located in spinal cord or brainstem
receives info from 1st order transmits to neurons in thalamus axon usually CROSSES the midline |
|
thrid order neurons
|
reside in one of sensory nuclei of thalamus
may change info before transmitting it to cerebral cortex. (Can only change FREQUENCY) |
|
fourth order neurons
|
located in the appropriate sensory receiving areas of the cerebral cortex
process info further |
|
higher-order neurons
|
located in cerebral cortex
|
|
modality
|
temp, light, chem, sound, injury, pressure, vibration
|
|
adaptation
|
reduction in discharge frequency during a sustained stimulus
|
|
slowly adapting receptors
|
long lasting stimulus produces prolonged repetitive discharge in the primary afferent neuron
slow reduction of APs till back to baseline |
|
rapidly adapting receptors
|
long-lasting stimulus produces only short-lived response
stimulus still applied, but no response |
|
pacinian corpuscles
|
cutaneous receptors
high freq vibration / pressure onion response to pressure PROPORTIONAL to pressure. |
|
choroid
|
vascular coat/ pigment
absorb light, supply nutrients to retina |
|
macula lutea
|
highest visual acuity / color
highest conc of cones and rods |
|
fovea
|
center of macula
most acute no rods |
|
in light,
Na channels _____, cells undergo __________ polarization |
close,
hyperpolarization / negative generator potential |
|
external ear
|
pinna (wing), external auditory meatus, auditory canal
|
|
tympanic membrane
|
flexible membrane that can respond t sound wave vibrations
|
|
eustachian tube
|
btwn nasopharynx and middle ear
|
|
otitis media
|
inflammation of the middle ear
kids - put tubes through tympanic membrane |
|
cochlea
|
snail shell
where organ of corti is |
|
organ of corti
|
apparatus responsible for the sense of hearing
|
|
hair cells - receptor cells
|
function as mechanoreceptors
|
|
vestibulocochlear nearve
|
combo of auditory nerve and vestibular nerve
|
|
conductive hearing loss
|
change in outer/middle ear impairs conduction of sound waves to inner ear
|
|
sensorineural hearing loss
|
impairment of organ of corti or it's CNS connection
causes: noise exposure, aging, ototoxicity, systemic diseases |
|
presbycusis
|
most common form of sensorineural
old age hearing loss |
|
tinnitus
|
ringing of ears
noise exposure, age |
|
mixed hearing loss
|
combination of conductive and sensorineural
|
|
functional hearing loss
|
indiv does not respond. caused by emotional or psychologic factors
|
|
vestibular nystagmus
|
involuntary, rapid, rhythmic movement of the eyes resulting from over stimulation of semicircular canal system
|
|
vertigo
|
sensation of spinning usual result of inflammation of semicircular canals
|
|
sclera
|
dense, white, opaque, covers 85% of eye, protective
|
|
cornea
|
covers 15%, lined with tear film
2/3 refractive power of eye |
|
lens
|
avascular
1/3 refractive power convex |
|
presbyotpia
|
loss of power of accommodation
eye remains focused on distant objects wear bifocal lenses |